Cross-talk between signaling pathways is increasingly recognized as integral to cellular function. We investigated whether the mitogen-activated protein kinase ( 
Introduction
Considerable experimental evidence has accumulated to suggest that many of the hormones and autacoids that inhibit vasopressin (AVP)' action in the mammalian collecting duct involve stimulation of protein kinase C (PKC) (1) . In this regard, many of the counterregulators of AVP action, such as prostaglandin E2 (2) , endothelin (3) , cholinergic agents (4) , and EGF (5), couple to phospholipase C. Also, direct activation of PKC itself inhibits AVP-stimulated adenylyl cyclase in cultured collecting duct cells (6) . However, in many cell types (7) , including the collecting duct (8) , stimulation of PKC also results in the activation of mitogen-activated protein kinases (MAPK).
Furthermore, we have recently shown an inverse relationship between the MAPK-activating properties of EGF and its inhibition of AVP stimulation of cAMP formation (8) . Thus it remained undefined whether the inhibition of cAMP generation by MAPK was dependent or independent of PKC. In this regard, it is interesting to note that cross-talk between the protein kinase A (PKA) pathway and growth factor-activated MAPK cascade has been recently reported. This is manifested by inhibition of MAPK activity by cAMP (9, 10) or PKA (11 ) in adipocytes, fibroblasts, and smooth muscle cells. However, such an inhibitory pathway is not universally present, as such inhibition is not evident in PC12 cells (10) . In view of our noted observation, it was attractive to consider the possibility that stimulation of the growth factor receptor by its attendant kinase cascade could in turn inhibit adenylyl cyclase activity. This study was undertaken to assess whether activation of the pathway alters hormonemediated stimulation of cAMP formation. More specifically, we examined whether Ras and Raf, two intermediary proteins in the cascade, exert an effect on the adenylyl cyclase pathway.
Methods
Cell culture. The M-1 immortalized mouse cortical collecting duct cell line was developed and kindly provided by Dr. Geza Fejes-Toth (Dartmouth Medical School, Hanover, NH) (12) . These cells represent a mixture of both principal and intercalated cells (13) . The cells were expanded and routinely grown in RPMI 1640 medium supplemented with 10% FCS, 10 mM Hepes, 24 mM NaHCO3, 100 U/ml penicillin, 100 ttg/ml streptomycin, 5 jtg/ml transferrin, and 1 1iM dexamethasone.
In experiments requiring basolateral AVP stimulation of PKA, cells were seeded on 25-mm diameter, 0.45-am pore Falcon cell culture inserts and grown to confluence.
Retrovirus-mediated gene transfections. The retroviral expression vector MV7 (14) in which the human T24 H-Ras cDNA (Gy 12 Va) had been inserted at the HindIII site was packaged into replicationdefective retrovirus in GP+E-86 cells (15). Similarly, a cDNA encoding a constitutively active Raf-l molecule (BXB Raf) (16) was inserted into pLXSN (17) and packaged. Polybrene (8 Ag/ml) was added to the retrovirus-containing medium from the GP+E-86 packaging cells and filtered before a 24-h incubation with subconfluent monolayers of M-1 cells. The infected M-l cells were then replated and selected for G418 resistance conferred by the neomycin (Neo) resistance gene encoded within pMV7 and pLXSN. Individual G418-resistant colonies were expanded and screened for expression of Ras and Raf by Western blotting.
Ras and Raf immunoblotting. For analysis of Ras expression, confluent dishes of the various M-1 clones were collected in 10 mM Hepes (pH 7.4), 2 mM MgCI2, 1 mM EGTA, 2 Mg/ml leupeptin, 2 Mg/ml aprotinin and disrupted by brief (15-s pulse) sonication (Vibra Cell; Sonics and Materials, Danbury, CT). After a 5-min centrifugation (2,000 g at 40C) to pellet intact cells and nuclei, plasma membranes were collected by a 5-min centrifugation (10,000 g at 40C). Equal aliquots of membrane proteins were resolved on an SDS, 12% polyacrylamide gel. For analysis of BXB Raf expression, soluble extracts of transfected cells were prepared with MAPK lysis buffer (see the following section), and equal aliquots were separated on SDS, 10% polyacrylamide gels.
The resolved proteins were transferred to nitrocellulose fillers that were then blocked with 1% nonfat dry milk in Tris-buffered saline, 0.1% Tween 20 (TTBS). The filter was incubated for 16 h with polyclonal antisera to Ras (Upstate Biotechnology, Inc., Lake Placid, NY) or Raf-l (Santa Cruz Biotechnology, Santa Cruz, CA). Bound antibodies were visualized with 125I-labeled protein A and autoradiography.
Assay of MAPK activity. M-1 cells were grown on 100-mm dishes to 50% confluence, incubated for 3-4 h in RPMI 1640 medium with 0.1% BSA, and exposed for 10 min to 100 nM TPA or a comparable volume of diluent DMSO. Treatment was terminated with aspiration of media, and cells were lysed with 1 ml of ice-cold MAPK lysis buffer (0.5% Triton X-100, 50 mM 3-glycerophosphate [pH 7.2], 2 mM MgCl2, 0.1 mM sodium orthovanadate, 1 mM EGTA, 1 mM DTT 5 pg/ml leupeptin, 0.2 U/ml aprotinin). Cells were collected with a rubber policeman, debris was removed by a 5-min centrifugation at 10,000 g, and supernatant cell-free extracts were used in the MAPK assay.
Cell-free extracts were partially purified on DEAE Sephacel as previously described (8) . Briefly, the extracts were adsorbed to 0.5-ml DEAE Sephacel columns (Pharmacia LKB, Piscataway, NJ), washed with three l-ml aliquots of buffer (50 mM /3-glycerophosphate [pH 7 .2], 0.1 mM sodium orthovanadate, 1 mM DTT, 1 mM EGTA), and eluted with 0.5 ml of the same buffer containing 500 mM NaCl. 20-p1 aliquots were incubated at 30°C for 10 min with 20-,l aliquots of a mixture containing 50 mM 63-glycerophosphate (pH 7.2), 0.1 mM sodium orthovanadate, 1 PKA assay. M-1 cells were grown on cell culture inserts to confluence. Cells were incubated for 3-4 h in RPMI 1640 medium with 0.1% BSA and then treated for 10 min by aspiration and replacement of the basolateral media alone with 1 nM AVP, 10 ,uM forskolin, or 1 pg/ml cholera toxin. Treatment was terminated by aspiration of media and lysis of cells with 0.5 ml of iced cell lysis buffer (0.5% Triton X-100, 50 mM ,/-glycerophosphate [pH 7.2], 2 mM MgCl2, 0.1 mM sodium orthovanadate, 1 mM EGTA, 1 mM DTT, 5 mg/ml leupeptin, 0.2 U/ ml aprotinin, and 0.1 mM 3-isobutyl-l-methylxanthine). Cell-free lysate was collected as previously described. with AVP, forskolin, or cholera toxin. Reactions were terminated, aliquots were spotted, and phosphorylated substrate was quantified via scintillation counter as previously described for MAPK assay. Statistical analysis. Comparisons between two experimental settings were performed by paired t test. When comparisons involved more than two groups, ANOVA was performed. Data are presented as means±SEM.
Results
Evidence for transfection of M-J cells. To assess whether the M-1 clones that were selected expressed the exogenous Ras protein, a Western blot of the plasma membrane preparation of each clone was performed using a specific anti-Ras antibody. As depicted in the top of Fig. 1 A, each of the clones screened showed markedly elevated expression of Ras protein when compared with the parent (M-1) cell line or controls transfected only with vector lacking a cDNA insert (Neo control), which do not reveal the protein.
Assessment offunctional expression. To assess whether the selected clones not only expressed the protein, but also possessed increased functional Ras activity, we examined the basal MAPK activity in the various clones. As seen in Fig. 1 Effect ofRas activation on A VP-stimulated PKA. To assess whether the overexpression of Ras alters AVP-stimulated PKA activity, the latter was evaluated. Fig. 2 shows the basal and AVP-stimulated PKA activity ratio in the parent line, the Neo control, and the four selected clones for study. Whereas basal activities were minimal and comparable in all settings, the response to AVP varied. The M-1 and Neo control achieved ratios of 0.82±0.03 and 0.83+0.06, respectively. It is of note that a similar response to AVP was also seen in each of four other Neo control clones that were tested to ascertain the variability of the PKA response to AVP among clones. Clone 9, whose basal MAPK is low, had a response to AVP indistinguishable from the Neo controls. In contrast, clones expressing higher basal MAPK activity showed marked inhibition of AVP-stimulated PKA activity. Thus, clone 6, with intermediate expression, had a ratio of only 0.56±0.05 (P < 0.01), and even more marked was the essential abolition of response in clone 5 (0.08±0.01), P < 0.01, and clone 10 (0.08±0.02), P < 0.01, which expressed higher MAPK activity. In fact, when AVPinduced PKA activity was compared with basal MAPK, there was a highly significant inverse correlation of n = -0.9207, P = 0.009, as depicted in Fig. 3 .
Site of Ras-induced PKA inhibition. To assess the level by which Ras was inhibiting the response to AVP, we evaluated Basal MAPK Activity Figure 3 . Correlation between basal MAPK activity and AVP-stimulated PKA in the studied clones. A marked negative correlation is observed.
the effects of 10 MM forskolin and the effects of preincubation with 1 Mg/ml cholera toxin. These results are shown in Table   I . In contrast to the response to AVP, neither the direct stimulation of adenylyl cyclase (forskolin) nor the endogenous Ga.
(cholera toxin) was affected by Ras. These data thus suggest a mechanism acting upstream from Gas, most likely at the AVP receptor.
Studies in cells overexpressing Raf To test further our hypothesis that the Ras-activated MAPK pathway is responsible for the inhibition of AVP signaling in M-1 cells, we introduced a constitutively activated form of the Ras target Raf into cells. Fig. 4 A shows an immunoblot analysis in which the presence of BXB Raf is seen in the transfected clones, but not in the Neo control. As depicted in Fig. 4 B, all three of the Raf clones displayed enhanced basal MAPK activity, indicating functional expression of the Raf construct. However, in contrast to our observation with the Ras-transfected clones, all of the Raf clones, despite exhibiting high basal MAPK, had intact responses to AVP that did not differ from those of the Neo control (Fig. 4 C) .
Discussion
It is now evident that cellular signaling involves an increasingly complex network of stimulatory and inhibitory pathways. These experiments were undertaken in an effort to define further the mechanisms of AVP resistance observed both functionally (5) and biochemically (6) Since stimulation of PKC itself increases MAPK activity in these cells (8) , it seems entirely possible that a component of this pathway is involved in the inhibitory effect. This possibility was further supported by our recent observation demonstrating a close correlation between the stimulation of MAPK with either EGF or carbachol and the agents' inhibition of AVP-stimulated cAMP generation (8) . In the current study, we used a molecular approach to stimulate specifically the growth receptor-activated protein kinase cascades. To this end, we transfected a cDNA encoding, a GTPase-deficient Ras polypeptide into M-1 cortical collecting duct cells, thereby overexpressing this protein, which is a proximal regulator of the MAPK cascade (19) (20) (21) . The selected clones overexpressed the protein of interest as assessed by immunoblot analysis (Fig. 1) . The absence of visible protein in the M-1 parental cell and the Neo control does not bespeak of the absence of Ras in such cells. In fact, we have found that even cells whose Ras activity is increased by EGF and PDGF show no visible protein on immunoblots, unlike transfectants that hyperexpress the protein (Nemenoff, R., personal communication). Thus, the immunoblot serves primarily as a screening devise for successful transfection and protein expression. Immunoblot also failed to predict the functional state of the cells as assessed by enhanced basal MAPK activity. Such functional expression was variable among clones, but was consistently reproducible in any given clone. The variability in turn provided a tool in the assessment of the role of this pathway in AVP-stimulated PKA stimulation. Whereas all of the clones transfected only with the neomycin resistance gene uniformly responded to AVP by stimulating PKA, the response of the Rastransfected clones seemed highly predictable from its degree of MAPK activation. We thus noted a highly significant (P = 0.009) inverse relationship (r = -0.9) between basal MAPK activity and AVP-stimulated PKA. It must be noted that though clone 10 had a marked suppression of the effect of AVP, clone 6, with only somewhat lower basal MAP kinase activity, still had a substantial PKA response. It is thus possible that there is a critical threshold of Ras activity expression beyond which the effect of AVP is fully inhibited. It is also of interest that we found no correlation between the clone's basal PKC activity and the AVP stimulation of PKA (r = -0.5, P = 0.29; data not shown).
We also undertook experiments to delineate the site of Ras inhibition. As the responses to both forskolin and cholera toxin were unperturbed, the catalytic unit of cyclase and the coupling G protein are unlikely targets. Thus the effect is most likely at the level of the AVP receptor. It is clear that protein kinase cascades target specific transcription factors and may thus act by decreasing the transcription of the AVP receptor. Alternatively, Ras or a protein distal to it could alter the internalization cycle of the receptor, thereby decreasing its availability to the plasma membrane.
The data we have described, in addition to lending support to the contention that a component of growth factor receptoractivated protein kinase cascade is involved in inhibition of AVP action, describe a novel inhibitory effect of Ras or a protein distal to it on AVP-stimulated adenylyl cyclase. In this regard, it is of interest to note that cAMP inhibits EGF (9), insulin (10), and PDGF (11) The previously mentioned effect of cAMP in inhibiting MAPK has been felt to be mediated by an effect on Raf-1 (22) that leads to activation of MAPK through the intermediary protein kinase MEK (23) . To assess whether Raf is in turn the mediator of the PKA inhibition described in this study, we developed transfected M-1 clones that overexpress this protein.
Despite displaying high MAPK in these clones, AVP consistently increased PKA. Such an observation in fact brings into question the inhibitory role of MAPK. The data thus point to distinct Ras-regulated pathways as the critical mediator of the inhibition seen in the current experiments as well as probably in the setting of the aforementioned agonist that activate this pathway via stimulation of PKC. It is now clear that Ras regulates the activation not only of Raf, but also of another serine threonine protein kinases, MEK kinase (24 
